MedDataX Logo

ST Elevation in Acute Chest Pain; Could Measurement of Lipoprotein-associated Phospholipase A2 (Lp-PLA2) be Helpful to the Clinician?

NCT ID: NCT01041339

Last Updated: 2015-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A blood test (2-3 cc peripheral venous blood) drawn /used from already available required lab tests to distinguish between pericarditis accompanied with electrocardiogram (ECG) signs mimicking infarction. A test of clinical potential if proven to be able to support either origin of acute chest pain etiology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Too many times young patients presenting with acute chest pain are referred to invasive angiography or treated with anticoagulation therapy a measure of detrimental effect in those inflicted with acute pericarditis.

A simple blood test (the PLAC test) may have some value in aiding rapid diagnosis saving need for cath.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Chest Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

LpPLA2 ST elevation acute pericarditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

acute chest pain ST elevation

patients admitted with acute chest pain sharing ST elevation in ER-ECG and elevated troponin

No interventions assigned to this group

controls

asymptomatic patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* acute chest pain
* acute ST elevation
* elevated troponin I

Exclusion Criteria

* patients with recent (\> 24 hour chest pain) myocardial infarction
* refusing to provide blood samples
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alexhander Izhaki

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexhander Izhaki

MD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander J Izhaki, MD

Role: PRINCIPAL_INVESTIGATOR

The E.Wolfson MC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The E.Wolfson MC

Holon, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pubmed/19121248?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1

Mayo Clin Proc. 2009;84(1):11-5.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0075-09-WOMC

Identifier Type: -

Identifier Source: org_study_id